The comet assay (OECD 489): reading DNA strand breaks, cell by cell

Some genotoxic effects only reveal themselves once damage has been converted into a stable mutation or a chromosomal rearrangement. The comet assay works earlier than that: it captures primary DNA damage — the strand breaks that appear within minutes of exposure — directly in individual cells. That immediacy is exactly why it has become one of the most versatile tools in modern genetic toxicology.

Also known as single-cell gel electrophoresis (SCGE), the comet assay measures DNA strand breaks with remarkable sensitivity, in almost any cell type, using very few cells. This article explains what it detects, how it is run, where the OECD guideline applies, and how it fits alongside the rest of the genotoxicity battery.

What the comet assay actually measures

The comet assay detects breaks in the DNA backbone. In its most widely used alkaline version (pH > 13), it reveals a broad spectrum of lesions:

• Single-strand breaks (SSB) and double-strand breaks (DSB);
• Alkali-labile sites (ALS), including abasic sites that convert to breaks under alkaline conditions;
• Incomplete excision-repair sites, where the repair machinery has cut but not yet resealed the strand.

Because these are primary events, the comet assay sees genotoxic activity before it is either repaired or fixed into a permanent mutation. That makes it a sensitive early-warning readout — and a mechanistic one.

Reading the “comet”

Under the microscope, an undamaged nucleus stays compact and round. A damaged one loses fragments and relaxed loops of DNA that migrate toward the anode during electrophoresis, trailing behind the nuclear “head” like the tail of a comet. The % of DNA in the tail (and derived metrics such as tail moment) quantifies the level of damage — the longer and brighter the tail, the more strand breaks.

How the assay is run

The workflow is elegant in its simplicity:

• Embedding — cells are suspended in low-melting-point agarose and spread on a microscope slide.
• Lysis — a high-salt, detergent buffer removes membranes and most proteins, leaving supercoiled DNA attached to the nuclear matrix.
• Alkaline unwinding — the slide is bathed in alkaline buffer, unwinding the DNA and exposing breaks.
• Electrophoresis — an electric field pulls broken DNA out of the head.
• Neutralisation, staining and scoring — a fluorescent dye reveals the comets, which are scored by image analysis.

Detecting oxidative damage too

A powerful variant introduces lesion-specific enzymes such as FPG or hOGG1, which convert oxidised bases (e.g. 8-oxoguanine) into strand breaks the assay can read. This enzyme-modified comet assay extends the readout from mechanical breakage to oxidative DNA damage — a mechanism central to many environmental and chemical exposures.

Where it sits in the regulatory framework

OECD Test Guideline 489 describes the in vivo mammalian alkaline comet assay. Under ICH S2(R1), the in vivo comet assay is an accepted second in vivo genotoxicity endpoint, typically paired with the in vivo micronucleus test to cover different tissues and mechanisms. It is especially valuable for assessing DNA damage in the specific organ of contact or of expected exposure (for example the liver).

There is no standalone OECD guideline for the in vitro comet assay, but the in vitro and 3D-tissue versions are widely used as complementary and mechanistic tools — to follow up an equivocal result, to investigate mode of action, or to screen early in development. Run on reconstructed human tissues, the comet assay becomes a credible New Approach Methodology, aligned with the 3Rs and with sectors where animal testing is banned.

Comet vs micronucleus: two questions, two answers

They are often confused, but they measure different things. The micronucleus test detects the consequences of unrepaired damage — chromosome fragments or whole chromosomes left outside the main nucleus after cell division (clastogenic and aneugenic events). The comet assay detects the strand breaks themselves, without requiring the cell to divide. Used together, they give a fuller picture: initial damage and its downstream fate.

When to choose the comet assay

• Mechanistic follow-up of a positive or equivocal battery result — is DNA breakage involved?
• Tissue-specific questions — damage in a particular organ or at the site of contact.
• Oxidative stress investigations, using the FPG/hOGG1-modified format.
• Animal-free programmes (cosmetics, some chemicals) using reconstructed human tissue.
• Early screening, where its speed and low sample requirement pay off.

Talk to our team

At GenEvolutioN, the comet assay is part of a predictive, GLP-compliant genetic toxicology offering built around human-relevant models. Whether you need a mechanistic follow-up, an oxidative-damage readout, or an animal-free strand-break assay on reconstructed tissue, our scientists can design the right approach for your programme.

Explore our GLP in-vitro toxicology services or browse the Knowledge Center for posters and datasheets from our team.